71 results
8-K
EX-10.1
COCP
Cocrystal Pharma Inc
10 Apr 23
Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30am
, and, except as contemplated by this Agreement, and has no present or contemplated agreement, undertaking, arrangement, obligation, indebtedness or commitment
424B5
COCP
Cocrystal Pharma Inc
5 May 21
Prospectus supplement for primary offering
4:01pm
to this prospectus supplement and the accompanying prospectus.
The offering is being underwritten on a firm commitment basis. The underwriters may offer
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
5 May 21
Cocrystal Pharma Announces $40 Million Bought Deal Offering of Common Stock
7:52am
into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 26,000,000 shares
424B5
illglh4rt1l9c8i5frlx
27 Aug 20
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
59j75qyws8gyhpv
27 Aug 20
Cocrystal Pharma Increases Previously Announced Bought Deal to $15.0 Million
6:02am
8-K
EX-99.1
6xpfhv2 oxvra9td8x
27 Aug 20
Cocrystal Pharma Announces $10.0 Million Bought Deal Offering
12:00am
424B5
jp02j 2xpadkksf9u
26 Aug 20
Prospectus supplement for primary offering
5:30pm
8-K
EX-1.1
fq6ezh0kg
2 Jul 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.2
97jod
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
8-K
EX-1.1
8qnvluxtax0olupnh2n
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
S-8
EX-10.1
58xti0sbzke0jm i42ju
11 May 18
Registration of securities for employees
4:16pm